Skip to main content
letter
. 2019 Jun 1;199(11):1438–1441. doi: 10.1164/rccm.201810-1899LE

Table 1.

Baseline Characteristics

Parameter Control (n = 5) ePAH (n = 4) PAH (n = 4) P Value
Age, yr 41.2 (22–60) 53.5 (44–62) 47.3 (22–64) 0.52
Sex, F 1 2 3 0.31
Race, white 5 3 3 0.55
Height, cm 170.9 (160–181.6) 169.2 (167.6–180.3) 170.7 (167.6–174) 0.96
Weight, kg 86 (72.6–134.6) 88 (68–107) 77.3 (56.2–119.7) 0.85
Years of symptoms 4.2 (1–10) 8.4 (7–10) 0.19
FEV1% predicted 103.7 (90–117) 87.9 (76–97) 82.9 (66–95) 0.12
FVC, % predicted 105.8 (100–115) 91.2 (83–118) 85.6 (64–110) 0.24
FEV1/FVC 79 (70–87) 72 (67–89) 80 (63–86) 0.50
mPAP, rest, mm Hg 18 (15–22) 41.6 (33–63) 0.01
PVR, rest, dyn · s/cm5 122.7 (81–143) 442 (322–548) 0.001
PCWP, rest, mm Hg 9.3 (7–11) 10 (7–16) 0.65
mPAP, exercise, mm Hg 36 (33–38)
PVR, exercise, dyn · s/cm5 154.6 (136–168)
PCWP, exercise, mm Hg 14.3 (11–18)
6MWD, m 485.2 (366–595) 463.2 (382–670) 0.083

Definition of abbreviations: 6MWD = 6-minute-walk distance; ePAH = exercise pulmonary arterial hypertension; mPAP = mean pulmonary arterial pressure; PAH = primary pulmonary arterial hypertension; PCWP = pulmonary capillary wedge pressure; PVR = pulmonary vascular resistance.

Continuous variables are represented as mean (minimum–maximum). Categorical variables are represented as counts.